NCT05737407

Brief Summary

The goal of this RCT is to demonstrate that, in neonatal anesthesia, the use of Lung Ultrasound (LUS) to guide choice of best Positive End-Expiratory Pressure (Peep) - the one that efficiently avoids lung atelectasis - leads to better gas exchange in the lung thus can lead to reduction of FiO2 applied to ventilatory setting in order to achieve same peripheral saturations of oxygen (SpO2). Specific aims of the study are:

  1. 1.to determine if LUS-guided PEEP choice in neonatal anesthesia, compared to standard PEEP choice, can lead to reduction of FiO2 applied to the ventilatory setting in order to maintain same SpO2s.
  2. 2.to determine if patients treated with LUS-guided PEEP will develop less postoperative pulmonary complications in the first 24 hours.
  3. 3.to compare static respiratory system compliance between groups.
  4. 4.to determine if there is a significant difference in hemodynamic parameters and amount of fluids infused or need for vasopressors between the two groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

1.3 years

First QC Date

February 9, 2023

Last Update Submit

May 9, 2024

Conditions

Keywords

Positive End Expiratory PressureNewbornAtelectasisOxygen ToxicityLung Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Change of FiO2 applied to the ventilatory setting in order to maintain same SpO2s.

    Difference between median SpO2/FiO2 ratio in the two groups

    During surgery

Secondary Outcomes (1)

  • Incidence of Postoperative Pulmonary Complications in the first post-operative 24 hours

    In the first 24 hours after the intervention/procedure/surgery

Other Outcomes (2)

  • Static compliance of the respiratory system between groups

    During surgery

  • Need for fluids/vasopressors

    During surgery

Study Arms (2)

LUS-guided Peep

EXPERIMENTAL

After induction of anesthesia and intubation, patients will be briefly turned onto their side and LUS will be performed in the posterior areas of the lung; PEEP will be adjusted in increments of 1 cmH20/minute starting from zero while maintaining visual inspection of LUS up to the point where signs of eventual subpleural consolidations and/or multiple B lines are not present anymore. FiO2 will be chosen as the minimum necessary to maintain SpO2 of 97-98%.

Other: LUS-guided choice of Peep

Standard setting of Peep

ACTIVE COMPARATOR

After induction, patients will be similarly scanned with LUS on their side but PEEP will be set at 4 cmH2O independently from results of LUS. FiO2 will be chosen as the minimum necessary to maintain SpO2 of 97-98%.

Other: Standard choice of Peep

Interventions

Choice of Peep guided by lung ultrasound to avoid atelectasis

LUS-guided Peep

Choice of Peep according to standard practice

Standard setting of Peep

Eligibility Criteria

Age33 Weeks - 50 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patients born after 33 weeks of gestationand up to the age of 50 post-conceptional weeks undergoing elective or urgent surgery requiring general anesthesia with endotracheal intubation

You may not qualify if:

  • born at less than 33 weeks of gestation
  • patients with signs or symptoms of cardiac or lung abnormalities or diseases
  • patients with suspected/confirmed immune diseases, known or suspected metabolic or genetic conditions
  • no parental consent is obtained

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vittore Buzzi Cildren's Hospital

Milan, 20154, Italy

RECRUITING

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2023

First Posted

February 21, 2023

Study Start

March 1, 2023

Primary Completion

June 30, 2024

Study Completion

December 15, 2024

Last Updated

May 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations